Has the worst been and gone for A2 Milk shares?

Are things sweet or sour for this fallen dairy business?

| More on:
A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side as though she is contemplating something.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • COVID-19 was a tough time for A2 Milk, with a number of earnings downgrades
  • But, it's now expecting growth in FY23 and it has been approved to import infant formula into the US
  • Experts think that the business is turning around

The A2 Milk Company Ltd (ASX: A2M) share price has seen plenty of volatility over the last couple of years.

Since the start of July 2020, A2 Milk shares have fallen by around 70%.

But, interestingly, the company has gone on a strong run over the past six months, rising by 44%.

So, with the recent rise from the low, can investors say that the worst is over?

A2 Milk is expecting growth

After a couple of years of revenue declines, with regular earnings downgrades, A2 Milk is finally expecting to deliver growth again.

When the dairy company announced its FY22 result, it also gave some comments about expectations for FY23. It said that it's expecting continued revenue and earnings growth.

The company said that it's expecting high single-digit growth in FY23. FY23 first-half growth is expected to be "significantly higher" than the FY23 second half.

The FY23 gross profit margin is expected to be "broadly in line" with FY22, with cost of goods sold headwinds related to increasing milk, ingredient and packaging costs offset by price increases, product mix benefits and cost mitigation initiatives.

Overall, the business is expecting earnings before interest, tax, depreciation and amortisation (EBITDA) growth in FY23 and a modest improvement in the EBITDA margin. It's expecting the FY23 second-half EBITDA margin to be better than the first half.

Is the worst over?

The latest win for the business came as the United States Food and Drug Administration approved A2 Milk to supply infant milk formula to the US to help with the shortage there.

The FDA had deferred further consideration of A2 Milk's US application. But, after ongoing engagement with the FDA, the agency has given A2 Milk approval to supply infant formula. The business is expecting to sell up to 1 million cans, all within the second half of FY23.

According to reporting by the Australian Financial Review, Spheria Asset Management portfolio manager Matt Booker said:

It's done reasonably well despite the challenges and headwinds, particularly in China. They are growing again, and rolling out into more stores there.

My feeling is they won that a2 category years ago. They sold the brand hard into China, and it's hard to displace – consumers tend not to like copycats and rather have the original brand. I think the brand still resonates with Chinese consumers.

They are coming off that low base in terms of margins. I think they can get back to the 20 per cent EBITDA margins from where they are now. This is a far more sustainable business today.

The AFR also referred to Barrenjoey head of consumer research Tom Kierath liking the ASX share, saying the US news is incrementally positive, but not a "game changer", and China remains its opportunity.

Snapshot

Over the last month, the A2 Milk share price is up around 4%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Two people in flying suits and helmets cruise in mid-air high above the earth with arms outstretched and the sun on the horizon.
Opinions

Prediction: WiseTech stock is going to soar past $150 in 2026

Here's what I expect from the stock in the next 12 months.

Read more »

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

2 unmissable ASX 300 shares that look too cheap to ignore!

I strongly believe these businesses are substantially undervalued.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

2 compelling ASX shares I'd buy in a heartbeat

These investments have great potential to deliver good returns…

Read more »

happy new financial year represented by fireworks
Best Shares

My 10 top stocks to buy to start the New Year off right

I think these ten stocks are primed for 2026.

Read more »

woman working on tablet
Opinions

2 incredible ASX 200 shares I'd buy with $2,000 right now

These stocks are some of the best that Australians can buy.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Dividend Investing

2 ASX dividend shares with yields above 7%!

These stocks offer investors significant potential income.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Opinions

1 unstoppable artificial intelligence stock you'll want to own in 2026

Here's what I've got my eye on this year.

Read more »

Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.
Dividend Investing

2 top ASX dividend share buys for passive income in January 2026

These stocks have a lot to offer for income-focused investors.

Read more »